John G. Singer 5/28/25 John G. Singer 5/28/25 'Competitive Convergence' Looks Like This Read More John G. Singer 5/22/25 John G. Singer 5/22/25 ‘Strategic Fit’ to Revolution Read More John G. Singer 5/20/25 John G. Singer 5/20/25 How to Ride Chaos Read More John G. Singer 5/8/25 John G. Singer 5/8/25 Why Rite Aid, Moderna, WPP and Starbucks are Flailing Read More John G. Singer 5/2/25 John G. Singer 5/2/25 Can Starbucks Help "Fix" Tesla? Read More John G. Singer 4/28/25 John G. Singer 4/28/25 Comparing the 'American Way of War' with the 'American Way of Healthcare' Read More John G. Singer 4/24/25 John G. Singer 4/24/25 The Invisible Hand Slaps Hard Read More John G. Singer 4/23/25 John G. Singer 4/23/25 Technology is More Irrelevant Than Ever Read More John G. Singer 4/17/25 John G. Singer 4/17/25 The Innovation Fallacy in Healthcare Read More John G. Singer 4/14/25 John G. Singer 4/14/25 The Delicate Art of 'Strategic Fit' Read More John G. Singer 4/11/25 John G. Singer 4/11/25 Killer Mayhem Read More John G. Singer 4/8/25 John G. Singer 4/8/25 Should Sanofi and Pepsi Combine as a New ‘Market Set’? Read More John G. Singer 4/3/25 John G. Singer 4/3/25 LillyDirect vs. NovoCare vs. PfizerForAll: May the Best Ecosystem Win Read More John G. Singer 3/27/25 John G. Singer 3/27/25 Modern Strategy Moves Like a Crab Read More John G. Singer 3/25/25 John G. Singer 3/25/25 Should PhRMA Acquire 23andMe? Read More John G. Singer 3/20/25 John G. Singer 3/20/25 "Norm Erosion" Looks Like This Read More John G. Singer 3/17/25 John G. Singer 3/17/25 Can Novartis Save the NHS? Read More John G. Singer 3/12/25 John G. Singer 3/12/25 What’s the Business Value of the VA to Eli Lilly? Read More John G. Singer 3/5/25 John G. Singer 3/5/25 A Slight Case of Overbombing Read More John G. Singer 3/3/25 John G. Singer 3/3/25 How to Make $164 Billion from “Malaria” — A Modern Strategy Story Read More Older Posts
John G. Singer 5/8/25 John G. Singer 5/8/25 Why Rite Aid, Moderna, WPP and Starbucks are Flailing Read More
John G. Singer 4/28/25 John G. Singer 4/28/25 Comparing the 'American Way of War' with the 'American Way of Healthcare' Read More
John G. Singer 4/8/25 John G. Singer 4/8/25 Should Sanofi and Pepsi Combine as a New ‘Market Set’? Read More
John G. Singer 4/3/25 John G. Singer 4/3/25 LillyDirect vs. NovoCare vs. PfizerForAll: May the Best Ecosystem Win Read More
John G. Singer 3/12/25 John G. Singer 3/12/25 What’s the Business Value of the VA to Eli Lilly? Read More
John G. Singer 3/3/25 John G. Singer 3/3/25 How to Make $164 Billion from “Malaria” — A Modern Strategy Story Read More
